One in three Australians with inflammatory bowel disease (IBD) left their medical consultations with misunderstandings about ...

An increasing number of individuals experience discomfort in the gut or are being diagnosed with intestinal conditions such ...

Domain Therapeutics ("Domain" or "the Company"), the GPCR experts harnessing deep receptor biology to develop breakthrough treatments for patients, today announces it has nominated and is progressing ...

The ongoing stock market rally attempt awaits this bullish trigger. Three market leaders to watch include Bowhead and ...

Horsham: Johnson & Johnson has announced that the Company ahs received approval from the U.S. Food and Drug Administration ...

A new study finds that gastrointestinal and psychological symptoms significantly impact disease activity in spondyloarthritis patients, highlighting the need for interdisciplinary care.

Tesla Chief Executive Elon Musk's work in President Donald Trump's White House, heading up the Department of Government Efficiency, or DOGE, has turned the EV giant into a "political symbol" resulting ...

With another inflammatory bowel disease (IBD) approval in the bag for Tremfya, Johnson & Johnson continues to make good on ...

EDT Organovo (ONVO) trading halted, news pendingLight Up your Portfolio with Spark:Easily identify stocks' risks and opportunities.

Overcoming adversity to make your dreams come true can be par for the course. For Jason Amador, who graduated from Parker ...

Increase awareness about colorectal cancer to promote early diagnosis and treatment, reducing mortality rates worldwide.

Rithm Property Trust Inc. (NYSE: RPT, "RPT" or the "Company") today announced the sale of an additional 84,232 shares of the ...